{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:24:10Z","timestamp":1771007050433,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T00:00:00Z","timestamp":1529107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11892-018-1028-y","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T22:57:51Z","timestamp":1529103471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Transplantation of Macroencapsulated Insulin-Producing Cells"],"prefix":"10.1007","volume":"18","author":[{"given":"Albert J.","family":"Hwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon C.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,16]]},"reference":[{"issue":"7","key":"1028_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc12-0063","volume":"35","author":"FB Barton","year":"2012","unstructured":"Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, et al. Improvement in outcomes of clinical islet transplantation: 1999\u20132010. Diabetes Care. 2012;35(7):1436\u201345.","journal-title":"Diabetes Care"},{"issue":"5","key":"1028_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrendo.2016.178","volume":"13","author":"AM Shapiro","year":"2017","unstructured":"Shapiro AM, Pokrywczynska M, Ricordi C. Clinical pancreatic islet transplantation. Nat Rev Endocrinol. 2017;13(5):268\u201377.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1028_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/TP.0b013e31820437f3","volume":"91","author":"DM Thompson","year":"2011","unstructured":"Thompson DM, Meloche M, Ao Z, Paty B, Keown P, Shapiro RJ, et al. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation. 2011;91(3):373\u20138.","journal-title":"Transplantation"},{"issue":"10","key":"1028_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1097\/TP.0b013e318172ca07","volume":"85","author":"DM Thompson","year":"2008","unstructured":"Thompson DM, Begg IS, Harris C, Ao Z, Fung MA, Meloche RM, et al. Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy. Transplantation. 2008;85(10):1400\u20135.","journal-title":"Transplantation"},{"issue":"2","key":"1028_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca FW, Millman JR, Gurtler M, Segel M, Van Dervort A, Ryu JH, et al. Generation of functional human pancreatic beta cells in vitro. Cell. 2014;159(2):428\u201339.","journal-title":"Cell"},{"issue":"10","key":"1028_CR6","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.5966\/sctm.2015-0079","volume":"4","author":"AD Agulnick","year":"2015","unstructured":"Agulnick AD, Ambruzs DM, Moorman MA, Bhoumik A, Cesario RM, Payne JK, et al. Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Stem Cells Transl Med. 2015;4(10):1214\u201322.","journal-title":"Stem Cells Transl Med"},{"issue":"11","key":"1028_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol. 2014;32(11):1121\u201333.","journal-title":"Nat Biotechnol"},{"issue":"13","key":"1028_CR8","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.15252\/embj.201591058","volume":"34","author":"HA Russ","year":"2015","unstructured":"Russ HA, Parent AV, Ringler JJ, Hennings TG, Nair GG, Shveygert M, et al. Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. EMBO J. 2015;34(13):1759\u201372.","journal-title":"EMBO J"},{"issue":"6","key":"1028_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3727\/096368917X694859","volume":"26","author":"Z Liu","year":"2017","unstructured":"Liu Z, Hu W, He T, Dai Y, Hara H, Bottino R, et al. Pig-to-primate islet xenotransplantation: past, present, and future. Cell Transplant. 2017;26(6):925\u201347.","journal-title":"Cell Transplant"},{"issue":"8","key":"1028_CR10","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.1021\/acsnano.7b01239","volume":"11","author":"R Chang","year":"2017","unstructured":"Chang R, Faleo G, Russ HA, Parent AV, Elledge SK, Bernards DA, et al. Nanoporous immunoprotective device for stem-cell-derived beta-cell replacement therapy. ACS Nano. 2017;11(8):7747\u201357.","journal-title":"ACS Nano"},{"issue":"5","key":"1028_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.tem.2009.12.010","volume":"21","author":"MY Donath","year":"2010","unstructured":"Donath MY, Boni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab. 2010;21(5):261\u20137.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"1028_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3727\/096368912X657486","volume":"22","author":"M Kumagai-Braesch","year":"2013","unstructured":"Kumagai-Braesch M, Jacobson S, Mori H, Jia X, Takahashi T, Wernerson A, et al. The TheraCyte device protects against islet allograft rejection in immunized hosts. Cell Transplant. 2013;22(7):1137\u201346.","journal-title":"Cell Transplant"},{"issue":"6","key":"1028_CR13","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/TP.0000000000001146","volume":"100","author":"G Faleo","year":"2016","unstructured":"Faleo G, Lee K, Nguyen V, Tang Q. Assessment of immune isolation of allogeneic mouse pancreatic progenitor cells by a macroencapsulation device. Transplantation. 2016;100(6):1211\u20138.","journal-title":"Transplantation"},{"key":"1028_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2337\/diab.43.9.1167","volume":"43","author":"DW Scharp","year":"1994","unstructured":"Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes. 1994;43:1167\u201370.","journal-title":"Diabetes"},{"key":"1028_CR15","doi-asserted-by":"publisher","unstructured":"\u2022 Carlsson PO, Espes D, Sedigh A, Rotem A, Zimerman B, Grinberg H, et al. Transplantation of macroencapsulated human islets within the bioartificial pancreas beta air to patients with type 1 diabetes mellitus. Am J Transplant. 2017; \n                      https:\/\/doi.org\/10.1111\/ajt.14642\n                      \n                    . This study shows that a macroencapsulation device with a relatively large pore size and exogenous oxygen supply can provide immune protection to allogeneic islets in non-immunosuppressed patients with T1D, but the kinetics of insulin secretion is blunted.","DOI":"10.1111\/ajt.14642"},{"issue":"1","key":"1028_CR16","first-page":"24","volume":"47","author":"Y Evron","year":"2015","unstructured":"Evron Y, Zimermann B, Ludwig B, Barkai U, Colton CK, Weir GC, et al. Oxygen supply by photosynthesis to an implantable islet cell device. Horm Metab Res. 2015;47(1):24\u201330.","journal-title":"Horm Metab Res"},{"issue":"13","key":"1028_CR17","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1073\/pnas.1201868109","volume":"109","author":"B Ludwig","year":"2012","unstructured":"Ludwig B, Rotem A, Schmid J, Weir GC, Colton CK, Brendel MD, et al. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci U S A. 2012;109(13):5022\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1028_CR18","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2337\/dc09-0744","volume":"32","author":"BE Tuch","year":"2009","unstructured":"Tuch BE, Keogh GW, Williams LJ, Wu W, Foster JL, Vaithilingam V, et al. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care. 2009;32(10):1887\u20139.","journal-title":"Diabetes Care"},{"issue":"1","key":"1028_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2337\/diacare.29.01.06.dc05-1270","volume":"29","author":"R Calafiore","year":"2006","unstructured":"Calafiore R, Basta G, Luca G, Lemmi A, Montanucci MP, Calabrese G, et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care. 2006;29(1):137\u20138.","journal-title":"Diabetes Care"},{"key":"1028_CR20","doi-asserted-by":"publisher","first-page":"14623","DOI":"10.1038\/srep14623","volume":"5","author":"GA Paredes-Juarez","year":"2015","unstructured":"Paredes-Juarez GA, Sahasrabudhe NM, Tjoelker RS, de Haan BJ, Engelse MA, de Koning EJ, et al. DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1. Sci Rep. 2015;5:14623.","journal-title":"Sci Rep"},{"issue":"3","key":"1028_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nbt.3462","volume":"34","author":"AJ Vegas","year":"2016","unstructured":"Vegas AJ, Veiseh O, Doloff JC, Ma M, Tam HH, Bratlie K, et al. Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol. 2016;34(3):345\u201352.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"1028_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.4030","volume":"22","author":"AJ Vegas","year":"2016","unstructured":"Vegas AJ, Veiseh O, Gurtler M, Millman JR, Pagliuca FW, Bader AR, et al. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med. 2016;22(3):306\u201311.","journal-title":"Nat Med"},{"issue":"6","key":"1028_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nmat4290","volume":"14","author":"O Veiseh","year":"2015","unstructured":"Veiseh O, Doloff JC, Ma M, Vegas AJ, Tam HH, Bader AR, et al. Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater. 2015;14(6):643\u201351.","journal-title":"Nat Mater"},{"key":"1028_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.addr.2014.02.007","volume":"67-68","author":"CK Colton","year":"2014","unstructured":"Colton CK. Oxygen supply to encapsulated therapeutic cells. Adv Drug Deliv Rev. 2014;67-68:93\u2013110.","journal-title":"Adv Drug Deliv Rev"},{"key":"1028_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biomaterials.2017.03.018","volume":"129","author":"MM Coronel","year":"2017","unstructured":"Coronel MM, Geusz R, Stabler CL. Mitigating hypoxic stress on pancreatic islets via in situ oxygen generating biomaterial. Biomaterials. 2017;129:139\u201351.","journal-title":"Biomaterials"},{"key":"1028_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2337\/diab.31.10.883","volume":"31","author":"S Bonner-Weir","year":"1982","unstructured":"Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes. 1982;31:883\u2013939.","journal-title":"Diabetes"},{"issue":"1","key":"1028_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/bit.26442","volume":"115","author":"P Buchwald","year":"2018","unstructured":"Buchwald P, Tamayo-Garcia A, Manzoli V, Tomei AA, Stabler CL. Glucose-stimulated insulin release: parallel perifusion studies of free and hydrogel encapsulated human pancreatic islets. Biotechnol Bioeng. 2018;115(1):232\u201345.","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"1028_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00007890-200101270-00006","volume":"71","author":"N Trivedi","year":"2001","unstructured":"Trivedi N, Keegan M, Steil GM, Hollister-Lock J, Hasenkamp WM, Colton CK, et al. Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses. Transplantation. 2001;71(2):203\u201311.","journal-title":"Transplantation"},{"issue":"2","key":"1028_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2337\/diabetes.53.2.360","volume":"53","author":"A Omer","year":"2004","unstructured":"Omer A, Duvivier-Kali VF, Aschenbach W, Tchipashvili V, Goodyear LJ, Weir GC. Exercise induces hypoglycemia in rats with islet transplantation. Diabetes. 2004;53(2):360\u20135.","journal-title":"Diabetes"},{"issue":"47","key":"1028_CR30","doi-asserted-by":"publisher","first-page":"19054","DOI":"10.1073\/pnas.1317561110","volume":"110","author":"B Ludwig","year":"2013","unstructured":"Ludwig B, Reichel A, Steffen A, Zimerman B, Schally AV, Block NL, et al. Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A. 2013;110(47):19054\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1028_CR31","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.2337\/db17-0065","volume":"66","author":"O Korsgren","year":"2017","unstructured":"\u2022 Korsgren O. Islet encapsulation: physiological possibilities and limitations. Diabetes. 2017;66(7):1748\u201354. This review provides more discussions on possible limitations of physiological insulin secretion from encapsulation insulin-producing cells.","journal-title":"Diabetes"},{"issue":"1","key":"1028_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/TP.0000000000000900","volume":"100","author":"E Korsgren","year":"2016","unstructured":"Korsgren E, Korsgren O. Glucose effectiveness: the mouse trap in the development of novel ss-cell replacement therapies. Transplantation. 2016;100(1):111\u20135.","journal-title":"Transplantation"},{"issue":"9","key":"1028_CR33","doi-asserted-by":"publisher","first-page":"E838","DOI":"10.1152\/ajpendo.00219.2014","volume":"307","author":"E Motte","year":"2014","unstructured":"Motte E, Szepessy E, Suenens K, Stange G, Bomans M, Jacobs-Tulleneers-Thevissen D, et al. Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts. Am J Physiol Endocrinol Metab. 2014;307(9):E838\u201346.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"1028_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.stemcr.2018.01.040","volume":"10","author":"T Robert","year":"2018","unstructured":"\u2022 Robert T, De Mesmaeker I, Stange GM, Suenens KG, Ling Z, Kroon EJ, et al. Functional beta cell mass from device-encapsulated hESC-derived pancreatic endoderm achieving metabolic control. Stem Cell Rep. 2018;10(3):739\u201350. This report, coupled with their earlier 2014 paper, shows that the outcome of encapsulated stem cell-derived insulin-producing cell products can change based on the types of encapsulation technology. Detailed analysis of beta-cell number and the insulin content and secretion on a per-cell basis is critically important to assess the functional beta-cell mass over time.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"1028_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nbt1393","volume":"26","author":"E Kroon","year":"2008","unstructured":"Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443\u201352.","journal-title":"Nat Biotechnol"},{"key":"1028_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2337\/diab.45.3.342","volume":"45","author":"T Maki","year":"1996","unstructured":"Maki T, Otsu I, O'Neil JJ, Dunleavy K, Mullon CJ, Solomon BA, et al. Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas. Diabetes. 1996;45:342\u20137.","journal-title":"Diabetes"},{"issue":"6","key":"1028_CR37","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1021\/acsbiomaterials.6b00814","volume":"3","author":"S Song","year":"2017","unstructured":"Song S, Yeung R, Park J, Posselt AM, Desai TA, Tang Q, et al. Glucose-stimulated insulin response of silicon nanopore-immunoprotected islets under convective transport. ACS Biomater Sci Eng. 2017;3(6):1051\u201361.","journal-title":"ACS Biomater Sci Eng"},{"issue":"6","key":"1028_CR38","doi-asserted-by":"publisher","first-page":"e1700184","DOI":"10.1126\/sciadv.1700184","volume":"3","author":"JD Weaver","year":"2017","unstructured":"Weaver JD, Headen DM, Aquart J, Johnson CT, Shea LD, Shirwan H, et al. Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites. Sci Adv. 2017;3(6):e1700184.","journal-title":"Sci Adv"},{"issue":"35","key":"1028_CR39","doi-asserted-by":"publisher","first-page":"9337","DOI":"10.1073\/pnas.1619216114","volume":"114","author":"AE Vlahos","year":"2017","unstructured":"Vlahos AE, Cober N, Sefton MV. Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets. Proc Natl Acad Sci U S A. 2017;114(35):9337\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1028_CR40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/TP.0b013e31817efc78","volume":"86","author":"AK Sorenby","year":"2008","unstructured":"Sorenby AK, Kumagai-Braesch M, Sharma A, Hultenby KR, Wernerson AM, Tibell AB. Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model. Transplantation. 2008;86(2):364\u20136.","journal-title":"Transplantation"},{"issue":"4","key":"1028_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3727\/000000003108746957","volume":"12","author":"E Rafael","year":"2003","unstructured":"Rafael E, Wu GS, Hultenby K, Tibell A, Wernerson A. Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: a morphometric study. Cell Transplant. 2003;12(4):407\u201312.","journal-title":"Cell Transplant"},{"issue":"2","key":"1028_CR42","doi-asserted-by":"publisher","first-page":"E263","DOI":"10.1073\/pnas.1708806115","volume":"115","author":"D An","year":"2018","unstructured":"An D, Chiu A, Flanders JA, Song W, Shou D, Lu YC, et al. Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes. Proc Natl Acad Sci U S A. 2018;115(2):E263\u2013e72.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1028_CR43","doi-asserted-by":"crossref","unstructured":"Gurlin RE, Keating MT, Li S, Lakey JR, de Feraudy S, Shergill BS, et al. Vascularization and innervation of slits within polydimethylsiloxane sheets in the subcutaneous space of athymic nude mice. J Tissue Eng 2017;8:2041731417691645.","DOI":"10.1177\/2041731417691645"},{"issue":"2","key":"1028_CR44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/term.2464","volume":"12","author":"AW Frei","year":"2018","unstructured":"Frei AW, Li Y, Jiang K, Buchwald P, Stabler CL. Local delivery of fingolimod from three-dimensional scaffolds impacts islet graft efficacy and microenvironment in a murine diabetic model. J Tissue Eng Regen Med. 2018;12(2):393\u2013404.","journal-title":"J Tissue Eng Regen Med"},{"issue":"11","key":"1028_CR45","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1097\/TP.0000000000000864","volume":"99","author":"AR Pepper","year":"2015","unstructured":"Pepper AR, Pawlick R, Gala-Lopez B, MacGillivary A, Mazzuca DM, White DJ, et al. Diabetes is reversed in a murine model by marginal mass syngeneic islet transplantation using a subcutaneous cell pouch device. Transplantation. 2015;99(11):2294\u2013300.","journal-title":"Transplantation"},{"issue":"5","key":"1028_CR46","first-page":"e2132","volume":"4","author":"G-L BL","year":"2016","unstructured":"BL G-L, Pepper AR, Dinyari P, Malcolm AJ, Kin T, Pawlick LR, et al. Subcutaneous clinical islet transplantation in a prevascularized subcutaneous pouch\u2014preliminary experience. CellR4. 2016;4(5):e2132.","journal-title":"CellR4"},{"key":"1028_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19382014.2016.1253652","volume":"8","author":"AR Pepper","year":"2016","unstructured":"Pepper AR, Bruni A, Pawlick RL, Gala-Lopez B, Rafiei Y, Wink J, et al. Long-term function and optimization of mouse and human islet transplantation in the subcutaneous device-less site. Islets. 2016;8:1\u20139.","journal-title":"Islets"},{"issue":"6","key":"1028_CR48","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.stemcr.2017.05.004","volume":"8","author":"AR Pepper","year":"2017","unstructured":"Pepper AR, Pawlick R, Bruni A, Wink J, Rafiei Y, O'Gorman D, et al. Transplantation of human pancreatic endoderm cells reverses diabetes post transplantation in a prevascularized subcutaneous site. Stem Cell Rep. 2017;8(6):1689\u2013700.","journal-title":"Stem Cell Rep"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-018-1028-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-018-1028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-018-1028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T19:30:47Z","timestamp":1560627047000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-018-1028-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,16]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1007\/s11892-018-1028-y","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,16]]},"assertion":[{"value":"16 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Albert J. Hwa serves on the SAB of Beta Cell NV and serves as a consultant for Sigilon Therapeutics.Gordon C. Weir serves on the SAB of Semma Therapeutics and Beta-O2.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"50"}}